August 25, 2021
Articles & Publications Project Profiles Global Health

Single-Dose Drug Delivery Fill-Finish Facility ... within an Accelerated Timeline of Fewer Than 7 Months

Part 3: ApiJect committed to creating emergency temporary fill-finish capacity for up to 45M doses a month of a candidate COVID-19 vaccine on BFS lines by the end of 2020. All of these BFS-packaged doses could then be used, if necessary, in ApiJect Prefilled Injectors for scalable, single-dose delivery.

Might interest you

View All
Global Health
Field Research Executive Summary – October 2025
Flora Koska, on the ApiLabs Field Research Network team, recently conducted a field research exercise in India to gathering user feedback on the latest Apiject prefilled injection device for delivery of injectable contraceptives. Read the report here.
Global Health
Enhancing Distributed Manufacturing and Vaccine Distribution through Blow-Fill-Seal Prefilled Drug Delivery Platforms, Upcoming Webinar Hosted by Xtalks
Adds BFS platform technology to provide large-scale production capacity for sterile drug dosage forms, including injectables, ophthalmics and inhalation Expands Amneal’s extensive domestic pharmaceutical manufacturing footprint News provided by Xtalks l Feb 10, 2025, 08:30 ET In this free webinar, learn about...
Global Health
Affordable Prefilled Devices Greatly Expand Access
At Apiject, we believe a higher level of universal expanded access can be achieved by providing injectable medicine and vaccines in single-use, prefilled injectors that are simple, affordable, and can overcome many “Last Mile” challenges.